Teladoc Health, Inc. reported $2.49B of revenue over the trailing twelve months, −2.1% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $2.49B (to Q2 2026). Net income: −$177M, trailing twelve months to Q2 2026. Free cash flow: $254M, trailing twelve months to Q2 2026. Operating margin: −7.5%, trailing twelve months to Q2 2026.

TDOCTeladoc Health, Inc.

Healthcare

$5.78-27% 1Y

$5.78

$4.4752 weeks$9.71

TDOC as reported

Teladoc Health, Inc. reported $2.49B of revenue over the trailing twelve months, −2.1% on the year before. 10 reported series are charted on this page, each one as filed.

$2.49B

Revenue, trailing twelve months · to Q2 2026 · −2.1% against the twelve months before

Net income: −$177M
Net income · −14% year on year · trailing twelve months to Q2 2026
Free cash flow: $254M
Free cash flow · −13% year on year · trailing twelve months to Q2 2026
Operating margin: −7.5%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for TDOC, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$2.49B	−2.1%	Q2 2026
Net income	−$177M	−14%	Q2 2026
EPS	−$0.99	−15%	Q2 2026
Gross margin	69%	n/a	Q2 2026
Operating margin	−7.5%	n/a	Q2 2026
Net margin	−7.2%	n/a	Q2 2026
ROE	−14%	n/a	Q2 2026
ROA	−6.8%	n/a	Q2 2026
ROIC	−2.8%	n/a	Q4 2021 · 18 quarters behind
Free cash flow	$254M	−13%	Q2 2026

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.